This study confirmed for the first time that miR-142-5p is abnormally upregulated in the serum of IS patients, and that miR-142-5p is positively correlated with the serum neurorelated markers NSE and S100β, suggesting that miR-142-5p is a biomarker of nerve injury and is involved in the development of IS. The gene discussed is S100B; the disease is injury.